SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4hbc'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1JGL_L_ESTL911_1 (IG GAMMA-1-CHAIN IG KAPPA-CHAIN)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN (Oryctolagus cuniculus)	5 / 10	GLY H 97 ALA L 34 TYR L 36 LEU L 46 TYR L 49	None	1.03A	1jglH-4hbcH: 23.3 1jglL-4hbcH: 15.0	1jglH-4hbcH: 53.57 1jglL-4hbcH: 27.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HH9_A_VIBA702_1 (THIAMIN PYROPHOSPHOKINASE)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN (Oryctolagus cuniculus)	5 / 9	TYR L 141 VAL L 197 SER L 178 SER L 163 ASN L 162	None	1.35A	2hh9A-4hbcL: 0.0 2hh9B-4hbcL: 0.0	2hh9A-4hbcL: 20.70 2hh9B-4hbcL: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HH9_B_VIBB701_1 (THIAMIN PYROPHOSPHOKINASE)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN (Oryctolagus cuniculus)	5 / 9	VAL L 197 SER L 178 SER L 163 ASN L 162 TYR L 141	None	1.35A	2hh9A-4hbcL: 0.0 2hh9B-4hbcL: 0.0	2hh9A-4hbcL: 20.70 2hh9B-4hbcL: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KEE_B_30BB500_2 (GENOME POLYPROTEIN)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN (Oryctolagus cuniculus)	3 / 3	PHE L 71 TYR L 92 LEU L 47	None	0.70A	3keeB-4hbcL: undetectable	3keeB-4hbcL: 20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N58_C_ADNC500_2 (ADENOSYLHOMOCYSTEINA SE)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	4 / 5	LEU H 110 GLN H 38 THR H 89 GLU H 150	None	1.32A	3n58C-4hbcH: undetectable	3n58C-4hbcH: 19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUE_B_SUEB1201_2 (NS3 PROTEASE, NS4A PROTEIN)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN (Oryctolagus cuniculus)	3 / 3	PHE L 71 TYR L 92 LEU L 47	None	0.78A	3sueB-4hbcL: undetectable	3sueB-4hbcL: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FU9_A_ACTA311_0 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN (Oryctolagus cuniculus)	3 / 3	GLN L 156 THR L 158 THR L 157	None	0.83A	4fu9A-4hbcL: undetectable	4fu9A-4hbcL: 20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FUF_A_ACTA310_0 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN (Oryctolagus cuniculus)	3 / 3	GLN L 156 THR L 158 THR L 157	None	0.81A	4fufA-4hbcL: undetectable	4fufA-4hbcL: 20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qvlV-4hbcH: undetectable 4qvlb-4hbcH: undetectable	4qvlV-4hbcH: 21.43 4qvlb-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qvlH-4hbcH: undetectable 4qvlN-4hbcH: undetectable	4qvlH-4hbcH: 21.43 4qvlN-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qvmV-4hbcH: undetectable 4qvmb-4hbcH: undetectable	4qvmV-4hbcH: 21.43 4qvmb-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qvmH-4hbcH: undetectable 4qvmN-4hbcH: undetectable	4qvmH-4hbcH: 21.43 4qvmN-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.45A	4qvpV-4hbcH: undetectable 4qvpb-4hbcH: undetectable	4qvpV-4hbcH: 21.43 4qvpb-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.45A	4qvpH-4hbcH: undetectable 4qvpN-4hbcH: undetectable	4qvpH-4hbcH: 21.43 4qvpN-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.45A	4qvqV-4hbcH: undetectable 4qvqb-4hbcH: undetectable	4qvqV-4hbcH: 21.43 4qvqb-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.45A	4qvqH-4hbcH: undetectable 4qvqN-4hbcH: undetectable	4qvqH-4hbcH: 21.43 4qvqN-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 10	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qvvV-4hbcH: undetectable 4qvvb-4hbcH: undetectable	4qvvV-4hbcH: 21.43 4qvvb-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 10	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qvvH-4hbcH: undetectable 4qvvN-4hbcH: undetectable	4qvvH-4hbcH: 21.43 4qvvN-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVW_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qvwV-4hbcH: undetectable 4qvwb-4hbcH: undetectable	4qvwV-4hbcH: 21.43 4qvwb-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVW_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.45A	4qvwH-4hbcH: undetectable 4qvwN-4hbcH: undetectable	4qvwH-4hbcH: 21.43 4qvwN-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.47A	4qvyV-4hbcH: undetectable 4qvyb-4hbcH: undetectable	4qvyV-4hbcH: 21.43 4qvyb-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.47A	4qvyH-4hbcH: undetectable 4qvyN-4hbcH: undetectable	4qvyH-4hbcH: 21.43 4qvyN-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qw0V-4hbcH: undetectable 4qw0b-4hbcH: undetectable	4qw0V-4hbcH: 21.43 4qw0b-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qw0H-4hbcH: undetectable 4qw0N-4hbcH: undetectable	4qw0H-4hbcH: 21.43 4qw0N-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qw1V-4hbcH: undetectable 4qw1b-4hbcH: undetectable	4qw1V-4hbcH: 21.43 4qw1b-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qw1H-4hbcH: undetectable 4qw1N-4hbcH: undetectable	4qw1H-4hbcH: 21.43 4qw1N-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.45A	4qw3V-4hbcH: undetectable 4qw3b-4hbcH: undetectable	4qw3V-4hbcH: 21.43 4qw3b-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.45A	4qw3H-4hbcH: undetectable 4qw3N-4hbcH: undetectable	4qw3H-4hbcH: 21.43 4qw3N-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qwuV-4hbcH: undetectable 4qwub-4hbcH: undetectable	4qwuV-4hbcH: 21.43 4qwub-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	4qwuH-4hbcH: undetectable 4qwuN-4hbcH: undetectable	4qwuH-4hbcH: 21.43 4qwuN-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QZT_A_RTLA201_0 (RETINOL-BINDING PROTEIN 2)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN (Oryctolagus cuniculus; Oryctolagus cuniculus)	5 / 12	ILE L 48 GLN L 6 TYR L 86 GLN H 38 LEU H 44	None	1.48A	4qztA-4hbcL: undetectable	4qztA-4hbcL: 21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.42A	5bxnV-4hbcH: undetectable 5bxnb-4hbcH: undetectable	5bxnV-4hbcH: 21.43 5bxnb-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.43A	5bxnH-4hbcH: undetectable 5bxnN-4hbcH: undetectable	5bxnH-4hbcH: 21.43 5bxnN-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 9	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.46A	5cz7V-4hbcH: undetectable 5cz7b-4hbcH: undetectable	5cz7V-4hbcH: 21.43 5cz7b-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.46A	5cz7H-4hbcH: undetectable 5cz7N-4hbcH: undetectable	5cz7H-4hbcH: 21.43 5cz7N-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	5d0xV-4hbcH: undetectable 5d0xb-4hbcH: undetectable	5d0xV-4hbcH: 21.43 5d0xb-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.44A	5d0xH-4hbcH: undetectable 5d0xN-4hbcH: undetectable	5d0xH-4hbcH: 21.43 5d0xN-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ECM_D_LEUD602_0 (JASMONIC ACID-AMIDO SYNTHETASE JAR1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	4 / 7	ALA H 88 THR H 87 VAL H 111 GLU H 85	None	0.71A	5ecmD-4hbcH: undetectable	5ecmD-4hbcH: 18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JLC_A_1YNA602_2 (LANOSTEROL 14-ALPHA DEMETHYLASE)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN (Oryctolagus cuniculus)	4 / 5	TYR L 87 GLY L 103 THR L 104 GLY H 176	None	0.92A	5jlcA-4hbcL: undetectable	5jlcA-4hbcL: 16.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.46A	5l5fV-4hbcH: undetectable 5l5fb-4hbcH: undetectable	5l5fV-4hbcH: 21.43 5l5fb-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.46A	5l5fH-4hbcH: undetectable 5l5fN-4hbcH: undetectable	5l5fH-4hbcH: 21.43 5l5fN-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.46A	5l66V-4hbcH: undetectable 5l66b-4hbcH: undetectable	5l66V-4hbcH: 21.43 5l66b-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	SER H 6 THR H 74 THR H 73 ALA H 20 THR H 18	None	1.45A	5l66H-4hbcH: undetectable 5l66N-4hbcH: undetectable	5l66H-4hbcH: 21.43 5l66N-4hbcH: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TWJ_A_SAMA201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 12	GLY H 164 SER H 188 THR H 139 LEU H 140 VAL H 193	None	0.95A	5twjA-4hbcH: undetectable	5twjA-4hbcH: 22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZBD_A_TRPA501_0 (FLAVIN-DEPENDENT L-TRYPTOPHAN OXIDASE VIOA)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN (Oryctolagus cuniculus)	5 / 10	ALA L 81 LEU L 78 ASP L 82 VAL L 108 GLY L 110	None	1.47A	5zbdA-4hbcL: 1.0	5zbdA-4hbcL: 17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZBD_B_TRPB501_0 (FLAVIN-DEPENDENT L-TRYPTOPHAN OXIDASE VIOA)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN (Oryctolagus cuniculus)	5 / 10	ALA L 81 LEU L 78 ASP L 82 VAL L 108 GLY L 110	None	1.47A	5zbdB-4hbcL: undetectable	5zbdB-4hbcL: 17.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CJK_C_ACTC301_0 (IMMUNOGLOBULIN FAB LIGHT CHAIN)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN (Oryctolagus cuniculus)	4 / 4	VAL L 15 GLY L 110 ASP L 111 ASP L 171	None	0.19A	6cjkC-4hbcL: 28.2	6cjkC-4hbcL: 85.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DRY_A_H8DA2001_0 (5HT2B RECEPTOR, BRIL CHIMERA)	4hbc	ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN (Oryctolagus cuniculus)	5 / 11	VAL H 206 THR H 204 VAL H 210 ALA H 120 VAL H 154	None	1.14A	6dryA-4hbcH: undetectable	6dryA-4hbcH: 15.75

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1JGL_L_ESTL911_1","IG GAMMA-1-CHAIN;IG KAPPA-CHAIN","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN;ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN","Oryctolagus cuniculus",5,"GLY H  97;ALA L  34;TYR L  36;LEU L  46;TYR L  49","None","1.03A","1jglH-4hbcH:23.3;1jglL-4hbcH:15.0","1jglH-4hbcH:53.57;1jglL-4hbcH:27.56"],["2HH9_A_VIBA702_1","THIAMIN PYROPHOSPHOKINASE;THIAMIN PYROPHOSPHOKINASE","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN","Oryctolagus cuniculus",5,"TYR L 141;VAL L 197;SER L 178;SER L 163;ASN L 162","None","1.35A","2hh9A-4hbcL:0.0;2hh9B-4hbcL:0.0","2hh9A-4hbcL:20.70;2hh9B-4hbcL:20.70"],["2HH9_B_VIBB701_1","THIAMIN PYROPHOSPHOKINASE;THIAMIN PYROPHOSPHOKINASE","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN","Oryctolagus cuniculus",5,"VAL L 197;SER L 178;SER L 163;ASN L 162;TYR L 141","None","1.35A","2hh9A-4hbcL:0.0;2hh9B-4hbcL:0.0","2hh9A-4hbcL:20.70;2hh9B-4hbcL:20.70"],["3KEE_B_30BB500_2","GENOME POLYPROTEIN","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN","Oryctolagus cuniculus",3,"PHE L  71;TYR L  92;LEU L  47","None","0.70A","3keeB-4hbcL:undetectable","3keeB-4hbcL:20.25"],["3N58_C_ADNC500_2","ADENOSYLHOMOCYSTEINASE","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",4,"LEU H 110;GLN H  38;THR H  89;GLU H 150","None","1.32A","3n58C-4hbcH:undetectable","3n58C-4hbcH:19.05"],["3SUE_B_SUEB1201_2","NS3 PROTEASE, NS4A PROTEIN","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN","Oryctolagus cuniculus",3,"PHE L  71;TYR L  92;LEU L  47","None","0.78A","3sueB-4hbcL:undetectable","3sueB-4hbcL:22.84"],["4FU9_A_ACTA311_0","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN","Oryctolagus cuniculus",3,"GLN L 156;THR L 158;THR L 157","None","0.83A","4fu9A-4hbcL:undetectable","4fu9A-4hbcL:20.99"],["4FUF_A_ACTA310_0","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN","Oryctolagus cuniculus",3,"GLN L 156;THR L 158;THR L 157","None","0.81A","4fufA-4hbcL:undetectable","4fufA-4hbcL:20.99"],["4QVL_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qvlV-4hbcH:undetectable;4qvlb-4hbcH:undetectable","4qvlV-4hbcH:21.43;4qvlb-4hbcH:20.70"],["4QVL_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qvlH-4hbcH:undetectable;4qvlN-4hbcH:undetectable","4qvlH-4hbcH:21.43;4qvlN-4hbcH:20.70"],["4QVM_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qvmV-4hbcH:undetectable;4qvmb-4hbcH:undetectable","4qvmV-4hbcH:21.43;4qvmb-4hbcH:20.70"],["4QVM_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qvmH-4hbcH:undetectable;4qvmN-4hbcH:undetectable","4qvmH-4hbcH:21.43;4qvmN-4hbcH:20.70"],["4QVP_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.45A","4qvpV-4hbcH:undetectable;4qvpb-4hbcH:undetectable","4qvpV-4hbcH:21.43;4qvpb-4hbcH:20.70"],["4QVP_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.45A","4qvpH-4hbcH:undetectable;4qvpN-4hbcH:undetectable","4qvpH-4hbcH:21.43;4qvpN-4hbcH:20.70"],["4QVQ_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.45A","4qvqV-4hbcH:undetectable;4qvqb-4hbcH:undetectable","4qvqV-4hbcH:21.43;4qvqb-4hbcH:20.70"],["4QVQ_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.45A","4qvqH-4hbcH:undetectable;4qvqN-4hbcH:undetectable","4qvqH-4hbcH:21.43;4qvqN-4hbcH:20.70"],["4QVV_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qvvV-4hbcH:undetectable;4qvvb-4hbcH:undetectable","4qvvV-4hbcH:21.43;4qvvb-4hbcH:20.70"],["4QVV_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qvvH-4hbcH:undetectable;4qvvN-4hbcH:undetectable","4qvvH-4hbcH:21.43;4qvvN-4hbcH:20.70"],["4QVW_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qvwV-4hbcH:undetectable;4qvwb-4hbcH:undetectable","4qvwV-4hbcH:21.43;4qvwb-4hbcH:20.70"],["4QVW_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.45A","4qvwH-4hbcH:undetectable;4qvwN-4hbcH:undetectable","4qvwH-4hbcH:21.43;4qvwN-4hbcH:20.70"],["4QVY_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.47A","4qvyV-4hbcH:undetectable;4qvyb-4hbcH:undetectable","4qvyV-4hbcH:21.43;4qvyb-4hbcH:20.70"],["4QVY_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.47A","4qvyH-4hbcH:undetectable;4qvyN-4hbcH:undetectable","4qvyH-4hbcH:21.43;4qvyN-4hbcH:20.70"],["4QW0_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qw0V-4hbcH:undetectable;4qw0b-4hbcH:undetectable","4qw0V-4hbcH:21.43;4qw0b-4hbcH:20.70"],["4QW0_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qw0H-4hbcH:undetectable;4qw0N-4hbcH:undetectable","4qw0H-4hbcH:21.43;4qw0N-4hbcH:20.70"],["4QW1_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qw1V-4hbcH:undetectable;4qw1b-4hbcH:undetectable","4qw1V-4hbcH:21.43;4qw1b-4hbcH:20.70"],["4QW1_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qw1H-4hbcH:undetectable;4qw1N-4hbcH:undetectable","4qw1H-4hbcH:21.43;4qw1N-4hbcH:20.70"],["4QW3_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.45A","4qw3V-4hbcH:undetectable;4qw3b-4hbcH:undetectable","4qw3V-4hbcH:21.43;4qw3b-4hbcH:20.70"],["4QW3_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.45A","4qw3H-4hbcH:undetectable;4qw3N-4hbcH:undetectable","4qw3H-4hbcH:21.43;4qw3N-4hbcH:20.70"],["4QWU_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qwuV-4hbcH:undetectable;4qwub-4hbcH:undetectable","4qwuV-4hbcH:21.43;4qwub-4hbcH:20.70"],["4QWU_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","4qwuH-4hbcH:undetectable;4qwuN-4hbcH:undetectable","4qwuH-4hbcH:21.43;4qwuN-4hbcH:20.70"],["4QZT_A_RTLA201_0","RETINOL-BINDING PROTEIN 2","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN;ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN","Oryctolagus cuniculus;Oryctolagus cuniculus",5,"ILE L  48;GLN L   6;TYR L  86;GLN H  38;LEU H  44","None","1.48A","4qztA-4hbcL:undetectable","4qztA-4hbcL:21.70"],["5BXN_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.42A","5bxnV-4hbcH:undetectable;5bxnb-4hbcH:undetectable","5bxnV-4hbcH:21.43;5bxnb-4hbcH:20.70"],["5BXN_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.43A","5bxnH-4hbcH:undetectable;5bxnN-4hbcH:undetectable","5bxnH-4hbcH:21.43;5bxnN-4hbcH:20.70"],["5CZ7_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.46A","5cz7V-4hbcH:undetectable;5cz7b-4hbcH:undetectable","5cz7V-4hbcH:21.43;5cz7b-4hbcH:20.70"],["5CZ7_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.46A","5cz7H-4hbcH:undetectable;5cz7N-4hbcH:undetectable","5cz7H-4hbcH:21.43;5cz7N-4hbcH:20.70"],["5D0X_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","5d0xV-4hbcH:undetectable;5d0xb-4hbcH:undetectable","5d0xV-4hbcH:21.43;5d0xb-4hbcH:20.70"],["5D0X_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.44A","5d0xH-4hbcH:undetectable;5d0xN-4hbcH:undetectable","5d0xH-4hbcH:21.43;5d0xN-4hbcH:20.70"],["5ECM_D_LEUD602_0","JASMONIC ACID-AMIDO SYNTHETASE JAR1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",4,"ALA H  88;THR H  87;VAL H 111;GLU H  85","None","0.71A","5ecmD-4hbcH:undetectable","5ecmD-4hbcH:18.88"],["5JLC_A_1YNA602_2","LANOSTEROL 14-ALPHA DEMETHYLASE","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN;ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN","Oryctolagus cuniculus",4,"TYR L  87;GLY L 103;THR L 104;GLY H 176","None","0.92A","5jlcA-4hbcL:undetectable","5jlcA-4hbcL:16.93"],["5L5F_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.46A","5l5fV-4hbcH:undetectable;5l5fb-4hbcH:undetectable","5l5fV-4hbcH:21.43;5l5fb-4hbcH:20.70"],["5L5F_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.46A","5l5fH-4hbcH:undetectable;5l5fN-4hbcH:undetectable","5l5fH-4hbcH:21.43;5l5fN-4hbcH:20.70"],["5L66_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.46A","5l66V-4hbcH:undetectable;5l66b-4hbcH:undetectable","5l66V-4hbcH:21.43;5l66b-4hbcH:20.70"],["5L66_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"SER H   6;THR H  74;THR H  73;ALA H  20;THR H  18","None","1.45A","5l66H-4hbcH:undetectable;5l66N-4hbcH:undetectable","5l66H-4hbcH:21.43;5l66N-4hbcH:20.70"],["5TWJ_A_SAMA201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"GLY H 164;SER H 188;THR H 139;LEU H 140;VAL H 193","None","0.95A","5twjA-4hbcH:undetectable","5twjA-4hbcH:22.43"],["5ZBD_A_TRPA501_0","FLAVIN-DEPENDENT L-TRYPTOPHAN OXIDASE VIOA","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN","Oryctolagus cuniculus",5,"ALA L  81;LEU L  78;ASP L  82;VAL L 108;GLY L 110","None","1.47A","5zbdA-4hbcL:1.0","5zbdA-4hbcL:17.07"],["5ZBD_B_TRPB501_0","FLAVIN-DEPENDENT L-TRYPTOPHAN OXIDASE VIOA","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN","Oryctolagus cuniculus",5,"ALA L  81;LEU L  78;ASP L  82;VAL L 108;GLY L 110","None","1.47A","5zbdB-4hbcL:undetectable","5zbdB-4hbcL:17.07"],["6CJK_C_ACTC301_0","IMMUNOGLOBULIN FAB LIGHT CHAIN","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN","Oryctolagus cuniculus",4,"VAL L  15;GLY L 110;ASP L 111;ASP L 171","None","0.19A","6cjkC-4hbcL:28.2","6cjkC-4hbcL:85.25"],["6DRY_A_H8DA2001_0","5HT2B RECEPTOR, BRIL CHIMERA","4hbc","ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN","Oryctolagus cuniculus",5,"VAL H 206;THR H 204;VAL H 210;ALA H 120;VAL H 154","None","1.14A","6dryA-4hbcH:undetectable","6dryA-4hbcH:15.75"]]